Counterfeit drug manufacturer fined 37.5 million UZS in Namangan
Authorities in Namangan have uncovered the production of a counterfeit drug called Besetol, which closely resembles the registered trademark medication Biseptol.
Justice authorities halted the manufacturing of the counterfeit drug, Besetol, which was produced by the Namangan-based company, LLC P.S. The drug’s name and branding were found to be misleadingly similar to Biseptol, a product owned by the Polish pharmaceutical company ADAMED PHARMA S.A.
Investigators determined that the imitation could deceive consumers into believing the counterfeit product was affiliated with the legitimate trademark.
As a result of the violation, LLC P.S. was fined 100 base calculation units (equivalent to 37.5 million UZS) for unauthorized use of a trademarked designation.
Authorities confirmed that the production and distribution of Besetol have been terminated.
Related News
12:21 / 27.05.2025
Hungarian pharma giants may launch medicine production in Uzbekistan
13:50 / 19.05.2025
Over 2,000 traffic violations reported in Namangan in a day
13:52 / 16.05.2025
Ministry of Economy refutes claims of price hikes in public hospital services
21:10 / 14.05.2025